Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04620096 · ClinicalTrials.gov registry record
MENstrual Symptom Tracking to Understand and Assess (Women) Living With Cystic Fibrosis
A clinical trial, sponsored by University of Washington.
- Completed
- Registry status
- 74
- Enrollment target
NCT04620096: Completed study, sponsored by University of Washington.
NCT04620096 is a clinical trial that has completed, run by University of Washington. The registered enrollment target is 74 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04620096 has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 74 participants
- Enrollment target
Study Summary
Cystic fibrosis (CF) affects men and women equally, but after the onset of puberty, women with CF have a lower life expectancy than men with CF. Despite these known differences, the link between CF symptom trends and the menstrual cycle remains critically understudied. To address this gap, this study will investigate changes in CF-specific symptoms among women with CF to evaluate whether and how they correlate with their menstrual cycle. Specifically, the investigators hope to examine whether CF-related symptoms change throughout the menstrual cycle, what the impact of those symptoms is on quality of life, and how feasible it is to use a period tracking app to track CF-related symptoms throughout the menstrual cycle. Investigators are asking women ages 18-45 with CF, who have regular menstrual cycles, to participate. Study procedures, including online surveys, period tracking, and interview, will take approximately 3 months.
Primary Outcome
Rating of Mild, Moderate, or Severe in the Clue smartphone app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2022-04-22 |
What the finished NCT04620096 record still lists
NCT04620096 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 74 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04620096 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04620096 about?
NCT04620096 is a clinical study titled "MENstrual Symptom Tracking to Understand and Assess (Women) Living With Cystic Fibrosis". Cystic fibrosis (CF) affects men and women equally, but after the onset of puberty, women with CF have a lower life expectancy than men with CF. Despite these known differences, the link between CF symptom trends and the menstrual cycle remains critically understudied. To address this gap, this stud...
What is the current status of trial NCT04620096?
This trial is currently completed. The enrollment target is 74 participants. The study started on 2021-06-01. Estimated completion is 2022-04-22.
Who is sponsoring clinical trial NCT04620096?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI